Selected papers from the 25th annual scientific meeting of the American Gynecological and Obstetrical SocietyAgos paperOral contraceptive discontinuation: do side effects matter?
Section snippets
Methods
This multicenter randomized trial was conducted between March 2003 and February 2005 at 3 University centers: Emory University, Atlanta, GA; Mt. Sinai Medical Center, New York, NY; and the University of Texas Southwestern Medical Center, Dallas, TX. Recruitment took place in their Family Planning and Teen Clinics. These clinics serve predominantly Latina and African American populations; they are funded in part by Title X and by other federal and state grants.
Clinical Center Institutional
Results
We enrolled 1720 women in the study. Four women enrolled twice, and we excluded their second enrollment, which left 1716 women. Subjects were mainly Hispanic, young, and poor; approximately 40% of the women had previous episodes of OC use (Table 1). Overall, 89% of eligible subjects completed the 3-month interview (n = 1498). Subsequently, 84% percent of eligible subjects completed the 6-month interview (n = 1369). Ten percent of the subjects (n = 171) were pregnant during the follow-up period.
Comment
This is a large community-based study that prospectively assessed side effects in women who were starting OCs. The 6-month discontinuation rate of 57% is comparable with smaller studies in similar patient populations.3, 4, 5 Our study is unusual because it used a structured questionnaire to assess symptoms in all OC users. We chose 4 possible side effects to assess in detail: weight change, headaches, moodiness, and sexual satisfaction. These symptoms emerged as those symptoms that were most
Discussion
Jeffrey Peipert, MD. OCs are highly effective when used consistently and correctly. However, OC users have a high rate of discontinuation that ranges from 18%-50%. Side effects are the most commonly reported reason to discontinue OCs.
Dr Westhoff et al evaluated perceived side effects among OC users and attempted to correlate these side effects with OC discontinuation. The study is a cohort analysis of a large multicenter randomized trial. The study population is mostly minority women seen at
References (14)
- et al.
Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons
Am J Obstet Gynecol
(1998) - et al.
Quick start: a novel oral contraceptive initiation method
Contraception
(2002) - et al.
Bleeding patterns after immediate versus conventional oral contraceptive initiation: a randomized controlled trial
Fertil Steril
(2003) - et al.
Depressive symptoms and Depo-Provera
Contraception
(1998) - et al.
Fertility, family planning, and women’s health: New data from the 1995 National Survey of Family Growth: National Center for Health Statistics
Vital Health Stat
(1997) - et al.
Adherence to medication
N Engl J Med
(2005) - et al.
Contraceptive use among adolescent mothers at six months postpartum
Obstet Gynecol
(1997)
Cited by (135)
Association of oral contraceptive pill use and depression among US women
2024, Journal of Affective DisordersTolerability and safety of the estetrol/drospirenone combined oral contraceptive: Pooled analysis of two multicenter, open-label phase 3 trials
2022, ContraceptionCitation Excerpt :Importantly, currently available COCs are associated with rare but serious cardiovascular adverse effects including venous thromboembolism (VTE) [9–11]. The adverse effects of COCs can be a barrier to use and result in discontinuation, with the potential for unintended pregnancies [12–15]. Therefore, a new COC with a favorable tolerability and safety profile could provide a beneficial option.
Maintenance Therapy for Preventing Endometrioma Recurrence after Endometriosis Resection Surgery – A Systematic Review and Network Meta-analysis
2022, Journal of Minimally Invasive GynecologyCitation Excerpt :However, Casper [56] suggested that the presence of supraphysiologic concentrations of estrogen with the OCP could rescue endometrial cell clusters deposited in the pelvis, and DNG might have better efficacy in treating endometriosis than OCP. Adverse effects are mild among OCP users; however, women with complaints such as increased headache and mood changes are more likely to discontinue OCP [57]. The most common complications of LNG-IUS and dienogest were vaginal spotting, which were self-limited and did not require additional treatment [8,33].
Combined oral contraceptives: Why, when, where?
2022, Polycystic Ovary Syndrome: Challenging Issues in the Modern Era of Individualized Medicine
This work was supported by National Institutes of Health grant 1RO1-HD42413.
Cite this article as: Westhoff CL, Heartwell S, Edwards S, et al. Oral contraceptive discontinuation: Do side effects matter? Am J Obstet Gynecol 2007;196:412.e1-412.e7.